TSE:HSM Helius Medical Technologies (HSM) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day RangeC$18.35▼C$18.3552-Week Range N/AVolume930 shsAverage Volume3,578 shsMarket CapitalizationC$42.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Helius Medical Technologies alerts: Email Address Ad Weiss RatingsThe next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.Click here to learn more. About Helius Medical TechnologiesHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.Read More Ad Weiss RatingsThe next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.Click here to learn more. HSM Stock News HeadlinesMay 12, 2024 | msn.comHelius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. CommercializationApril 17, 2024 | msn.comHelius Medical Technologies (HSDT) Price Target Decreased by 9.73% to 15.78July 26, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.April 1, 2024 | msn.comHelius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial ChallengesMarch 28, 2024 | benzinga.comRecap: Helius Medical Tech Q4 EarningsFebruary 10, 2024 | msn.comHelius Medical Technologies Boosts Finance with Stock SalesNovember 1, 2023 | morningstar.comHelius Medical Technologies Inc Class A HSDTAugust 10, 2023 | msn.comHelius Medical Technologies GAAP EPS of -$0.06 beats by $0.06, revenue of $0.25M beats by $0.06MJuly 26, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.May 11, 2023 | msn.comHelius Medical Tech: Q1 Earnings InsightsMay 10, 2023 | msn.comEarnings Outlook For Helius Medical TechApril 13, 2023 | benzinga.comHelius Medical Tech Stock (NASDAQ:HSDT), Guidance and ForecastMarch 14, 2023 | msn.comHelius Medical Tech's Return On Capital Employed InsightsJanuary 23, 2023 | yahoo.comHelius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022December 23, 2022 | msn.comLooking Into Helius Medical Tech's Return On Capital EmployedNovember 18, 2022 | msn.comHelius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the UpgradeOctober 25, 2022 | forbes.comHelius Medical TechnologiesMay 4, 2022 | nz.finance.yahoo.comEmerging Markets Report: The Air We ShareSee More Headlines Receive HSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolTSE:HSM CUSIPN/A CIKN/A Webheliusmedical.com Phone215-944-6100FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.74 Current Ratio4.20 Quick Ratio3.58 Sales & Book Value Annual SalesC$477,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.71 Book ValueC$3.61 per share Price / BookN/AMiscellaneous Outstanding Shares2,318,000Free FloatN/AMarket CapC$42.54 million OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Dane Carl Andreeff (Age 55)Pres, CEO & Director Comp: $2.5kMr. Jeffrey S. Mathiesen CPA (Age 60)CPA, CFO & Treasurer Comp: $5kMs. Joyce N. LaViscount (Age 59)COO & Sec. Comp: $388.3kDr. Jonathan Mark Sackier (Age 63)Consultant Comp: $201.65kMr. Frederick FantazziaVP of Sales & Marketing- North AmericaDr. Brian W. Bapty Ph.D. (Age 52)VP of Strategy and Bus. Devel. Mr. Mark LenoVP & GM of Canadian OperationsMore ExecutivesKey CompetitorsProtech Home MedicalCVE:PTQProtech Home MedicalCVE:PHMTheralase TechnologiesCVE:TLTVentriPoint DiagnosticsCVE:VPTAurora SpineCVE:ASGView All Competitors HSM Stock Analysis - Frequently Asked Questions How do I buy shares of Helius Medical Technologies? Shares of HSM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Helius Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include VanEck Junior Gold Miners ETF (GDXJ), Sleep Country Canada (ZZZ), Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ) and ATCO (ACO.X). This page (TSE:HSM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.